Novartis will launch an agreed tender offer for the balance of Eon Labs shares at $31 a share, a 25 per cent premium over the pre-takeover speculation price of $24.75 a share.I mentioned Eon Labs (ELAB) last week for its technical breakout.
Feb 21, 2005
Biotech buying
According to the FT($$),
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment